Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19

NCT05083039 · clinicaltrials.gov ↗
COMPLETED
Status
1500
Enrollment
OTHER_GOV
Sponsor class

Conditions

Sponsor

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products